Open Access Open Access  Restricted Access Subscription or Fee Access

New paradigms in drug R&D: A personal perspective

David C U'Prichard

Abstract


The Author discusses the recent productivity problems in the pharmaceutical industry, in the context of his 30 year career, and the current responses of the industry driven strongly by disaggregation of the historic R&D model, new fluidites of capital access, and the impacts of genomics and globalization.

Keywords


pharma R&D; venture capital; new R&D models; globalization; virtualization

Full Text:

PDF


DOI: http://dx.doi.org/10.5912/jcb502

Refbacks

  • There are currently no refbacks.




Copyright © thinkBiotech LLC